LianBio
LIANY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $29 | $482 | $177 | $661 |
| - Cash | $52 | $439 | $79 | $228 |
| + Debt | $0 | $2 | $4 | $5 |
| Enterprise Value | -$23 | $46 | $102 | $437 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | $3 | $313 | -$109 | -$196 |
| % Margin | – | – | – | – |
| Net Income | $2 | $311 | -$110 | -$197 |
| % Margin | – | – | – | – |
| EPS Diluted | 0.023 | 2.87 | -1.02 | -1.83 |
| % Growth | -99.2% | 381.4% | 44.3% | – |
| Operating Cash Flow | $4 | $259 | -$99 | -$164 |
| Capital Expenditures | $0 | -$0 | -$2 | -$1 |
| Free Cash Flow | $4 | $259 | -$101 | -$165 |